comparemela.com
  1. Home
  2. Live Updates
  3. Mmune Aim Us00901b1052 - Breaking News

Latest Breaking News On - Mmune aim us00901b1052 - Page 1 : comparemela.com

AIM ImmunoTech to Discuss First Quarter 2023 Financial Results on May 16, 2023 and Host Conference Call and Webcast

OCALA, Fla., May 09, 2023 AIM ImmunoTech Inc.  , an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and. | May 9, 2023

United statesThomask equelsChristopher mcaleerJenene thomasImmunotech incChief executive officerTech conferenceAim immunotech inc stock exchangePress releaseMmune aim us00901b1052

AIM ImmunoTech to Report Full Year 2022 Financial Results on March 31, 2023 and Host Inaugural Quarterly Conference Call and Webcast

OCALA, Fla., March 27, 2023 AIM ImmunoTech Inc. , an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and. | March 27, 2023

United statesChristopher mcaleerThomask equelsImmunotech incCompany on twitterChief executive officerTech conferenceAim immunotech inc stock exchangePress releaseMmune aim us00901b1052

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.